Mood Disorders

Should we go up? Researchers performed a dose-response meta-analysis of randomized controlled trials in acute phase schizophrenia.

How can transcranial magnetic stimulation help patients with treatment-resistant depression?

How does schizophrenia as a pathology differ from normal human experience?

What is the connection between inflammation and mood disorders?

How do you manage the 4 most common adverse effects of antipsychotic medications?

Results suggest that psilocybin therapy may prove to be helpful in improving quality of life for patients with cancer.

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

In older adults with bipolar disorder, what evidence is there to guide treatment?

A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?

What are the risk factors for and prevalence overweight and obesity in patients with first-episode drug-naïve major depressive disorder?

Doctor, can I have an extra cup of caffeine? Researchers performed a systematic review of studies of caffeine consumption and clinical symptoms in patients with bipolar disorder.

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.

Is depression the same today as it was in the 17th century? Is it the same thing in Nigeria as it is in the United States? One of the foremost historians of psychiatry weighs in.

Sleep problems are understudied, underdiagnosed, and undertreated.

In this conversation, a former APA president discusses mystical and meditative experiences, reconciling psychoanalysis and neuroscience, and tensions surrounding the medical model.

What treatments could handle both psychiatric emergencies and long-standings mental health conditions—in a hurry?

One doctor at the APA Virtual meeting explains how ketamine can rebuild spine and synaptic proteins in the brain, but may be difficult to actually prescribe to patients.

Prazosin appears to be effective and perhaps the best medication for selected patients, including those with bipolar disorder.

A high-powered lawyer faces her toughest opponent yet: mental illness stigma.

A study finds that testing genetic variations can predict outcomes and medication blood levels in patients with depression.

Is this phase 2 trial the end of the road for a potential new treatment?

Research on the prevalence of ADHD in Black individuals in the United States highlights the need for future research in this underrepresented group.

A rare genetic disorder may have unrecognized psychological consequences.

A new test screens for bipolar disorder with respectable accuracy

In addressing mood disorders associated with infertility, sometimes the cure may be worse than the disease.

Daily routine and structure will decrease a patient's stress and give them a sense of accomplishment.

A healthy diet can improve mood and effectiveness of antidepressant medications. Here's why your patients should be eating healthier.

Where do migraines and psychiatric disorders intersect? Learn more.

Valproate/divalproex appears to be considerably overused in the US; the use of lithium, second-generation antipsychotics, and carbamazepine should be more prominent in treatment decisions for patients with bipolar mania.

COVID-19 has spurred many changes leading to wider adoption of various technologies to support public health efforts. But even data collected for the greater good can have unintended negative or punitive consequences.